Contact | 
Print version | 
PDF version | 
Send article | 
RSS feed
Emerson to automate major expansion project for GE Healthcare in Norway
19 Oct 2005 -
Emerson Process Management has been chosen by GE Healthcare as a working partner in a major new project to increase the production capacity at its Lindesnes plant in Norway. Faster time to market, easier validation, and operations excellence based on real-time diagnostics in smart field devices led to the selection of Emerson.
Emerson is developing the solution and managing the project. The company is installing its PlantWeb® digital plant architecture with the DeltaV(TM) digital automation system and FOUNDATION fieldbus digital communications technology for the major project. Value to Emerson is estimated at $3.5M.
Emerson's scope of supply includes project management, configuration and start-up. The PlantWeb digital approach will include Rosemount® measurement instruments, Micro Motion® Coriolis flowmeters, Rosemount Analytical instruments, and Fisher® valves with FIELDVUE® digital valve controllers. The company's AMS(TM) Suite: Intelligent Device Manager will monitor diagnostics delivered by field devices, and provide alerts and guidance for maintenance effectiveness.
Also included in the package are tailor-made solutions for removing 5000 I/O from the existing PLC systems and integrating these into the new scheme. The complete system will be a combination of the new and existing systems and will have a capacity of around 7500 I/O. Work commenced during the summer of 2004 with a planned completion date of February 2007.
GE Healthcare's Lindesnes plant is situated in the municipality of Lindesnes, 70km south of Kristiansand. It has around 400 employees and produces the active ingredients used in contrast agents. The project includes new installations and alterations to the existing production plant, designed to meet the increased market demand for its X-ray and MRI contrast agents. The work is being carried out in stages, and the entire factory is being built in accordance with national and international standards related to the pharmaceutical manufacturing industry.
Top